Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)
NCT00483106
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
885
Enrollment
OTHER
Sponsor class
Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG:
Ritalin
DRUG:
Placebo
Sponsor
McGill University